title: Fatal brainstem haemorrhage after intracranial stenting: how much anti-platelet medication should we give?
authors.forename: Wilhelm
authors.initials: W
authors.lastname: Kuker
authors.forename: Jonathan
authors.initials: J
authors.lastname: Downer
authors.forename: Martino
authors.initials: M
authors.lastname: Cellerini
authors.forename: Dennis
authors.initials: D
authors.lastname: Briley
authors.forename: Ursula
authors.initials: U
authors.lastname: Schulz
mesh_terms: D000368:Aged; D001807:Blood Vessel Prosthesis / Q000009:adverse effects*; D020203:Brain Stem Hemorrhage, Traumatic / Q000209:etiology* / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D017809:Fatal Outcome; D006801:Humans; D002532:Intracranial Aneurysm / Q000601:surgery*; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects*; D015607:Stents / Q000009:adverse effects*
chemical_list: D010975:Platelet Aggregation Inhibitors